ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 172 filers reported holding ANTARES PHARMA INC in Q1 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,129,000 | +196.3% | 275,284 | +188.2% | 0.00% | 0.0% |
| Q4 2020 | $381,000 | -39.6% | 95,522 | -59.1% | 0.00% | -50.0% |
| Q3 2020 | $631,000 | -53.5% | 233,727 | -52.7% | 0.00% | -60.0% |
| Q2 2020 | $1,357,000 | -30.3% | 493,821 | -40.1% | 0.01% | -47.4% |
| Q1 2020 | $1,947,000 | -39.9% | 825,061 | +19.8% | 0.02% | -13.6% |
| Q4 2019 | $3,237,000 | +173.4% | 688,621 | +94.3% | 0.02% | +144.4% |
| Q3 2019 | $1,184,000 | -66.9% | 354,432 | -67.4% | 0.01% | -69.0% |
| Q2 2019 | $3,582,000 | -45.7% | 1,088,657 | -50.0% | 0.03% | -6.5% |
| Q1 2019 | $6,600,000 | +122.9% | 2,177,754 | +100.0% | 0.03% | +3.3% |
| Q4 2018 | $2,961,000 | +765.8% | 1,088,657 | +968.1% | 0.03% | +2900.0% |
| Q3 2018 | $342,000 | – | 101,928 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
| JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
| Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
| Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
| PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
| MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
| FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |